OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanobiomaterials to modulate natural killer cell responses for effective cancer immunotherapy
Aun Raza, Gustavo Rodrigues Rossi, Taskeen Iqbal Janjua, et al.
Trends in biotechnology (2022) Vol. 41, Iss. 1, pp. 77-92
Closed Access | Times Cited: 18
Aun Raza, Gustavo Rodrigues Rossi, Taskeen Iqbal Janjua, et al.
Trends in biotechnology (2022) Vol. 41, Iss. 1, pp. 77-92
Closed Access | Times Cited: 18
Showing 18 citing articles:
NK cell-based tumor immunotherapy
Hao Zhang, Yang Li, Tingting Wang, et al.
Bioactive Materials (2023) Vol. 31, pp. 63-86
Open Access | Times Cited: 44
Hao Zhang, Yang Li, Tingting Wang, et al.
Bioactive Materials (2023) Vol. 31, pp. 63-86
Open Access | Times Cited: 44
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 12
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 12
Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR
Pui Yeng Lam, Natacha Omer, J. Wong, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Pui Yeng Lam, Natacha Omer, J. Wong, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Immunomodulatory and immune-toxicological role of nanoparticles: Potential therapeutic applications
Somnath Sau, Alo Dey, Pritam Pal, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112251-112251
Closed Access | Times Cited: 7
Somnath Sau, Alo Dey, Pritam Pal, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112251-112251
Closed Access | Times Cited: 7
Hybrid adipocyte-derived exosome nano platform for potent chemo-phototherapy in targeted hepatocellular carcinoma
Xinying Liu, Jiaxin Zhang, Shunzhe Zheng, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 168-181
Open Access | Times Cited: 6
Xinying Liu, Jiaxin Zhang, Shunzhe Zheng, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 168-181
Open Access | Times Cited: 6
Surface-engineered nanoparticles in cancer immune response and immunotherapy: Current status and future prospects
Jun Chen, Xiufeng Cong
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113998-113998
Open Access | Times Cited: 22
Jun Chen, Xiufeng Cong
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113998-113998
Open Access | Times Cited: 22
Biomimetic nanosystems harnessing NIR-II photothermal effect and hypoxia-responsive prodrug for self-amplifying and synergistic tumor treatment
Lu Wang, Tianjiao Wang, Yushi Zhang, et al.
Nano Today (2024) Vol. 57, pp. 102395-102395
Closed Access | Times Cited: 5
Lu Wang, Tianjiao Wang, Yushi Zhang, et al.
Nano Today (2024) Vol. 57, pp. 102395-102395
Closed Access | Times Cited: 5
Immunomodulation, Toxicity, and Therapeutic Potential of Nanoparticles
Ashutosh Pandey, Abhinava K. Mishra
BioTech (2022) Vol. 11, Iss. 3, pp. 42-42
Open Access | Times Cited: 20
Ashutosh Pandey, Abhinava K. Mishra
BioTech (2022) Vol. 11, Iss. 3, pp. 42-42
Open Access | Times Cited: 20
Biomimetic Cell-Derived Nanoparticles: Emerging Platforms for Cancer Immunotherapy
Tingting Hu, Yuezhou Huang, Jing Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1821-1821
Open Access | Times Cited: 11
Tingting Hu, Yuezhou Huang, Jing Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1821-1821
Open Access | Times Cited: 11
Recent advances in metal-based nanomaterials for malignant bone tumor therapy
Weicong Liu, Manli Guo, Yuanyuan Hu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117427-117427
Closed Access
Weicong Liu, Manli Guo, Yuanyuan Hu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117427-117427
Closed Access
Nanomaterials for Natural Killer Cell-Based Immunoimaging and Immunotherapies in Cancer
Saji Uthaman, Gabriel Cutshaw, Saman Ghazvini, et al.
ACS Applied Materials & Interfaces (2022) Vol. 15, Iss. 44, pp. 50708-50720
Open Access | Times Cited: 12
Saji Uthaman, Gabriel Cutshaw, Saman Ghazvini, et al.
ACS Applied Materials & Interfaces (2022) Vol. 15, Iss. 44, pp. 50708-50720
Open Access | Times Cited: 12
M1/M2 macrophages: origin, phenotype, methods of production, interaction with natural killer cells and trophoblast
A. S. Zhguleva, Maria Zementova, S. А. Selkov, et al.
Medical Immunology (Russia) (2024) Vol. 26, Iss. 3, pp. 425-448
Open Access | Times Cited: 1
A. S. Zhguleva, Maria Zementova, S. А. Selkov, et al.
Medical Immunology (Russia) (2024) Vol. 26, Iss. 3, pp. 425-448
Open Access | Times Cited: 1
Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy
Stefania Douka, Vasilis Papamoschou, Monica Raimo, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1143-1143
Open Access | Times Cited: 1
Stefania Douka, Vasilis Papamoschou, Monica Raimo, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1143-1143
Open Access | Times Cited: 1
Nanoparticle-mediated efficient up-regulation of GSDMD-N to induce pyroptosis and enhance NK cell-based cancer immunotherapy
Zixian Huang, Chunfang Wei, Yi Chen, et al.
Acta Biomaterialia (2024)
Closed Access | Times Cited: 1
Zixian Huang, Chunfang Wei, Yi Chen, et al.
Acta Biomaterialia (2024)
Closed Access | Times Cited: 1
Advances in Anti-tumor Application of ROS Enzymatic-mimetic Catalysts
Lingfeng Jiang, Menglin Luo, Jiawei Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 26, pp. 12287-12308
Closed Access
Lingfeng Jiang, Menglin Luo, Jiawei Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 26, pp. 12287-12308
Closed Access
Dual-responsive natural killer cell nano-engagers for cancer immunotherapy via inhibiting IL-6/JAK2/STAT3 pathway
Xiangrui Meng, Zhan Xue, Hang Xiao, et al.
Chemical Engineering Journal (2024) Vol. 499, pp. 156423-156423
Closed Access
Xiangrui Meng, Zhan Xue, Hang Xiao, et al.
Chemical Engineering Journal (2024) Vol. 499, pp. 156423-156423
Closed Access
Influencing inter-cellular junctions with nanomaterials
Jinping Wang, Guo-Ying Zhang, Kuoran Xing, et al.
Advances in Colloid and Interface Science (2024) Vol. 336, pp. 103372-103372
Closed Access
Jinping Wang, Guo-Ying Zhang, Kuoran Xing, et al.
Advances in Colloid and Interface Science (2024) Vol. 336, pp. 103372-103372
Closed Access
Hybrid Adipocyte-Derived Exosome Nano Platform for Potent Chemo-Phototherapy in Targeted Hepatocellular Carcinoma
Xinying Liu, Jiaxin Zhang, Shunzhe Zheng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Xinying Liu, Jiaxin Zhang, Shunzhe Zheng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
